{"SPADE_UN_26276": {"Sequence Information": {"Peptide Name": "4B8M", "Sequence": "PPXF", "Sequence Length": 4, "Biological Activity": ["Antiviral", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Cytoplasmic Protein\n2. Virus replication\n3. Immunomodulation", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Structural and Biofunctional Insights into the Cyclo(Pro-Pro-Phe-Phe-) Scaffold from Experimental and In Silico Studies: Melanoma and Beyond", "Pubmed ID": "35806175", "Reference": "Int J Mol Sci. 2022;23:7173", "Author": "Bojarska J, Breza M, Jaremko M, Czyz M, Gajos-Michniewicz A, Zimecki M, Kaczmarek K, Madura ID, Wojciechowski JM, Wolf WM", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/35806175"}, {"Title": "Antiviral Activity of a Cyclic Pro-Pro- β3-HoPhe-Phe Tetrapeptide against HSV-1 and HAdV-5", "Pubmed ID": "35684487", "Reference": "Molecules. 2022;27:3552", "Author": "Zaczyńska E, Kaczmarek K, Zabrocki J, Artym J, Zimecki M", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/35684487"}], "SPADE ID": "SPADE_UN_26276", "Similar Sequences": [{"SPADE_ID": "SPADE_N_00189", "Similarity": 1.0, "Sequence": "TPVVNPPFLQQT"}, {"SPADE_ID": "SPADE_N_00338", "Similarity": 1.0, "Sequence": "AKCIKNGKGCREDQGPPFCCSGFCYRQVGWARGYCKNR"}, {"SPADE_ID": "SPADE_N_00450", "Similarity": 1.0, "Sequence": "SDIKPTGRIDNQCKRMCSATYGNGKCAADCRSDGFSSGQCFTSPPFDNRCCCNN"}], "Hemolytic Activity": "Mouse splenocytes:15% Cell death=50 µg/ml", "Target Organism": "Human melanoma DMBC28(10-20% Killing=50µM),Human melanoma DMBC29(10-20% Killing=50µM),Human lung carcinoma A549(no activity data),Human Adenovirus AdV-5(IC50 REP=>25µg/ml),HSV-1(IC50 REP=>25µg/ml)"}}}